CITI/CALL/PFIZER INC/32/0.1/19.06.25 Share Price

Warrant

DE000KH9RQN2

Market Closed - Boerse Frankfurt Warrants 11:11:34 28/06/2024 pm IST
0.13 EUR 0.00% Intraday chart for CITI/CALL/PFIZER INC/32/0.1/19.06.25
Current month-23.53%
1 month-18.75%
Date Price Change
28/24/28 0.13 0.00%
27/24/27 0.13 +18.18%
26/24/26 0.11 -15.38%
25/24/25 0.13 0.00%
24/24/24 0.13 +8.33%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 11:11 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Citi Citi
WKN KH9RQN
ISINDE000KH9RQN2
Date issued 13/09/2023
Strike 32 $
Maturity 19/06/2025 (355 Days)
Parity 10 : 1
Emission price 0.53
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.56
Lowest since issue 0.089
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 0.8744
Difference Strike 4.02 $
Difference Strike %+12.56%
Intrinsic value 0.000000

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.98 USD
Average target price
31.92 USD
Spread / Average Target
+14.07%
Consensus